Condition
Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Total Trials
1
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Petct Imaging Sessions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 1 (1)
Trial Status
Active Not Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Petct Imaging Sessions1
- 18ffluorthanatrace1
Active Sponsors
- Abramson Cancer Center at Penn Medicine1
Top Investigators
Abramson Cancer Center at Penn Medicine